Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Research
    • Structural Heart Disease
    • TAVR
    • Therapies
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home
News You Need to Know Today
News Alert: FDA announces recall of nearly 88,000 implantable cardiac devices
Friday, August 19, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death

The recall is related to short circuit protection (SCP) alerts that were causing the devices to send reduced-energy electric shocks. There have been 27 customer complaints about the issue so far.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The recall is related to short circuit protection (SCP) alerts that were causing the devices to send reduced-energy electric shocks. There have been 27 customer complaints about the issue so far.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: J&J puts research on hold | The best diets for heart health | Boston Scientific enters IVL arms race
A hospital's guide to higher CCTA payments | Compensation rising for cardiology APPs | Loving tributes to UW cardiologist
Boston Scientific enters IVL arms race | J&J pauses use of PFA system in US | Surgery outperforms PCI
Heart device impresses FDA | Stryker acquires Inari Medical for $4.9B | CES 2025 | Limiting TAVR complications
Popular drug benefits heart bypass patients | Why a Boston Scientific TAVR valve fell short | TPVR device gains CE mark approval
The best diets for heart health | Young child treated with heart device for very first time | ‘A victory for TAVR’
Screening via CCTA and AI goes to trial | Practical approaches to post-stroke AF monitoring | Top video content from 2024

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Sitemap
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • AI in Healthcare
  • Cardiovascular Business
  • HealthExec
  • Health Imaging
  • Radiology Business
 
© 2024 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme